Viewing Study NCT03433703


Ignite Creation Date: 2025-12-24 @ 7:37 PM
Ignite Modification Date: 2025-12-25 @ 5:17 PM
Study NCT ID: NCT03433703
Status: TERMINATED
Last Update Posted: 2019-12-06
First Post: 2018-02-09
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Trial to Evaluate Safety and Efficacy of Treatment of Physician Choice (TPC) Following First-Line Treatment of Lenvatinib in Subjects With Unresectable Hepatocellular Carcinoma (uHCC)
Sponsor: Eisai Inc.
Organization: